Literature DB >> 9781906

Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations.

J B Beckwith1.   

Abstract

Nephrogenic rests (NR) are abnormally persistent clusters of embryonal cells, representing microscopic malformations (dysplasias) of the developing kidney. Though NR are best known as precursors of Wilms tumor (WT), many alternative fates are observed, and most rests are destined for eventual atresia. Biological and clinical distinctions between the two major NR categories, perilobar and intralobar rests (PLNR and ILNR) are emphasized. PLNR occur in fetal overgrowth and with certain overgrowth syndromes. ILNR are frequently associated with deletions or mutations of WT1. Data are presented concerning the prevalence of NR in general pediatric autopsy populations, and in selected syndromes. The age at diagnosis of WT was determined for the largest series of patients with WT-associated syndromes reported to date. These data provide a basis for determining how long patients with these conditions are at risk for WT development.

Entities:  

Mesh:

Year:  1998        PMID: 9781906     DOI: 10.1002/(sici)1096-8628(19981002)79:4<268::aid-ajmg7>3.0.co;2-i

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  42 in total

Review 1.  Current management of wilms' tumor.

Authors:  Leah Nakamura; Michael Ritchey
Journal:  Curr Urol Rep       Date:  2010-02       Impact factor: 3.092

2.  Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumors.

Authors:  Raisa Vuononvirta; Neil J Sebire; Anthony R Dallosso; Jorge S Reis-Filho; Richard D Williams; Alan Mackay; Kerry Fenwick; Anita Grigoriadis; Alan Ashworth; Kathy Pritchard-Jones; Keith W Brown; Gordan M Vujanic; Chris Jones
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

Review 3.  Wilms' tumour: a complex enigma to decipher.

Authors:  María José Robles-Frías; Michele Biscuola; María Angeles Castilla; María Angeles López-García; Felicia Sánchez-Gallego; José Palacios
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

4.  Sequential WT1 and CTNNB1 mutations and alterations of beta-catenin localisation in intralobar nephrogenic rests and associated Wilms tumours: two case studies.

Authors:  Ryuji Fukuzawa; Rosemary W Heathcott; Helen E More; Anthony E Reeve
Journal:  J Clin Pathol       Date:  2006-12-15       Impact factor: 3.411

5.  Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.

Authors:  Jane Lange; Susan M Peterson; Janice R Takashima; Yevgeny Grigoriev; Michael L Ritchey; Robert C Shamberger; J Bruce Beckwith; Elizabeth Perlman; Daniel M Green; Norman E Breslow
Journal:  J Urol       Date:  2011-06-17       Impact factor: 7.450

6.  Loss of heterozygosity at 11p13 and 11p15 in Wilms tumor: a study of 22 cases from India.

Authors:  Elanthenral Sigamani; Mohammad Nahidul Wari; Venkateswaran K Iyer; Sandeep Agarwala; Arundhati Sharma; Sameer Bakhshi; Amit Dinda
Journal:  Pediatr Surg Int       Date:  2013-01-05       Impact factor: 1.827

7.  Glypican-3 mRNA expression level in Wilms tumor: correlation with histological type, stage, and outcome.

Authors:  Md Nahidul Wari; Archana George Vallonthaiel; Aijaz Ahmed; Deepali Saxena; Venkateswaran K Iyer; Sandeep R Mathur; Sandeep Agarwala; Sameer Bakhshi; V Srinivas; P Chattopadhyaya; Arundhati Sharma; S Datta Gupta; Amit Dinda
Journal:  Pediatr Surg Int       Date:  2017-04-21       Impact factor: 1.827

8.  Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus.

Authors:  Reyhan El-Kares; Pierre-Alain Hueber; Miriam Blumenkrantz; Diana Iglesias; Kim Ma; Nada Jabado; Daniel G Bichet; Paul Goodyer
Journal:  Pediatr Nephrol       Date:  2009-03-18       Impact factor: 3.714

9.  K-Ras, H-Ras, N-Ras and B-Raf mutation and expression analysis in Wilms tumors: association with tumor growth.

Authors:  Efterpi Dalpa; Victor Gourvas; Nikolaos Soulitzis; Demetrios A Spandidos
Journal:  Med Oncol       Date:  2016-12-09       Impact factor: 3.064

10.  Wilms' tumor: An update.

Authors:  Hemant B Tongaonkar; Sajid S Qureshi; Purna A Kurkure; Mary-Ann A Muckaden; Brijesh Arora; Thyavihalli B Yuvaraja
Journal:  Indian J Urol       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.